Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2952088783;88784;88785 chr2:178554901;178554900;178554899chr2:179419628;179419627;179419626
N2AB2787983860;83861;83862 chr2:178554901;178554900;178554899chr2:179419628;179419627;179419626
N2A2695281079;81080;81081 chr2:178554901;178554900;178554899chr2:179419628;179419627;179419626
N2B2045561588;61589;61590 chr2:178554901;178554900;178554899chr2:179419628;179419627;179419626
Novex-12058061963;61964;61965 chr2:178554901;178554900;178554899chr2:179419628;179419627;179419626
Novex-22064762164;62165;62166 chr2:178554901;178554900;178554899chr2:179419628;179419627;179419626
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Ig-146
  • Domain position: 77
  • Structural Position: 164
  • Q(SASA): 0.3279
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/R None None 1.0 D 0.889 0.723 0.735079807728 gnomAD-4.0.0 2.40064E-06 None None None None I None 0 0 None 0 0 None 0 0 2.625E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.755 likely_pathogenic 0.6979 pathogenic -0.208 Destabilizing 1.0 D 0.775 deleterious D 0.566011635 None None I
G/C 0.91 likely_pathogenic 0.8816 pathogenic -0.745 Destabilizing 1.0 D 0.83 deleterious D 0.572562247 None None I
G/D 0.9081 likely_pathogenic 0.8746 pathogenic -0.78 Destabilizing 1.0 D 0.874 deleterious D 0.586967174 None None I
G/E 0.9502 likely_pathogenic 0.9285 pathogenic -0.963 Destabilizing 1.0 D 0.854 deleterious None None None None I
G/F 0.984 likely_pathogenic 0.9769 pathogenic -1.106 Destabilizing 1.0 D 0.859 deleterious None None None None I
G/H 0.9737 likely_pathogenic 0.9628 pathogenic -0.483 Destabilizing 1.0 D 0.849 deleterious None None None None I
G/I 0.98 likely_pathogenic 0.9691 pathogenic -0.458 Destabilizing 1.0 D 0.863 deleterious None None None None I
G/K 0.9752 likely_pathogenic 0.9687 pathogenic -0.71 Destabilizing 1.0 D 0.853 deleterious None None None None I
G/L 0.9737 likely_pathogenic 0.9638 pathogenic -0.458 Destabilizing 1.0 D 0.851 deleterious None None None None I
G/M 0.9862 likely_pathogenic 0.9805 pathogenic -0.416 Destabilizing 1.0 D 0.832 deleterious None None None None I
G/N 0.9367 likely_pathogenic 0.9214 pathogenic -0.306 Destabilizing 1.0 D 0.837 deleterious None None None None I
G/P 0.9983 likely_pathogenic 0.9976 pathogenic -0.346 Destabilizing 1.0 D 0.886 deleterious None None None None I
G/Q 0.9569 likely_pathogenic 0.9441 pathogenic -0.645 Destabilizing 1.0 D 0.891 deleterious None None None None I
G/R 0.9487 likely_pathogenic 0.9333 pathogenic -0.237 Destabilizing 1.0 D 0.889 deleterious D 0.587572587 None None I
G/S 0.6925 likely_pathogenic 0.6406 pathogenic -0.372 Destabilizing 1.0 D 0.83 deleterious D 0.58676537 None None I
G/T 0.9206 likely_pathogenic 0.894 pathogenic -0.501 Destabilizing 1.0 D 0.85 deleterious None None None None I
G/V 0.9547 likely_pathogenic 0.9332 pathogenic -0.346 Destabilizing 1.0 D 0.848 deleterious D 0.588178 None None I
G/W 0.9821 likely_pathogenic 0.9713 pathogenic -1.239 Destabilizing 1.0 D 0.843 deleterious None None None None I
G/Y 0.9684 likely_pathogenic 0.9541 pathogenic -0.893 Destabilizing 1.0 D 0.858 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.